New combo therapy aims to improve surgery success for pancreatic cancer patients
Disease control
Recruiting now
This study tests a combination of four drugs (liposomal irinotecan, 5-fluorouracil/calcium folinate, oxaliplatin, and adebrelimab) plus radiation before surgery for people with pancreatic cancer that is either removable or borderline removable but has risk factors. The goal is to…
Phase: PHASE2 • Sponsor: Ningbo Medical Center Lihuili Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC